arrow
A

Alessio Crippa

karolinska institutet
H指数:28
被引数:4,018

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ORGAN-SPECIFIC SIDE EFFECTS FOLLOWING CURATIVE-INTENT RADIOTHERAPY AND RADICAL PROSTATECTOMY FOR NON-METASTATIC PROSTATE CANCER: A POPULATION-BASED COHORT STUDY

非转移性前列腺癌根治性放疗和根治性前列腺切除术后的器官特异性副作用:一项基于人群的队列研究

2026-05-010
PRE
Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial

Crippa, A.; De Laere, B.; Discacciati, A.; Larsson, B.; Persson, M.; Johansson, S.; D’hondt, S.; Hjälm-Eriksson, M.; Pettersson, L.; Enblad, G.; 等. 循环肿瘤DNA分数在转移性去势抵抗性前列腺癌中的预后价值:ProBio平台试验结果. Eur. Urol. Oncol. 2025. [Google Scholar] [CrossRef]

2025-04-210
OAAI
Efficacy of carboplatin in patients with metastatic castration-resistant prostate cancer: Results from the biomarker-driven, randomised, outcome-adaptive ProBio trial

卡铂在转移性去势抵抗性前列腺癌患者中的疗效:来自生物标志物驱动的、随机、结果适应性ProBio试验的结果

2024-09-011
PRE
Health-related quality of life outcomes of androgen receptor pathway inhibitors versus taxanes versus standard of care in metastatic castration-resistant prostate cancer: Results from the ProBio trial

雄激素受体通路抑制剂与紫杉烷类药与标准治疗在转移性去势抵抗性前列腺癌中的健康相关生活质量结局:ProBio试验结果

2024-09-010
PRE
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial (Aug, 10.1038/s41591-024-03204-2, 2024)
2024-08-280
OAAI
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

雄激素受体途径抑制剂和紫杉烷类药物在转移性前列腺癌中的应用: 一项结果适应性随机平台试验

2024-08-201
OAAI
Androgen receptor pathway inhibitors or taxanes for patients with metastatic castration-resistant prostate cancer: A direct comparison in ProBio, a randomized, outcome-adaptive, biomarker-driven platform trial
2023-10-011
PRE
Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose-response meta-analysis of large prospective studies

非职业性体力活动与心血管疾病、癌症和死亡率结局的风险: 大型前瞻性研究的剂量-反应荟萃分析

2023-02-2867
OAAI
Clinical trial design during and beyond the pandemic: the I-SPY COVID trial
2022-01-2013
OA